Results 51 to 60 of about 48,901 (273)
BackgroundWe studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent edoxaban in patients with atrial fibrillation (AF). Methods and ResultsENGAGE AF‐TIMI 48 was a randomized trial that compared 2
Haiyan Xu +9 more
doaj +1 more source
ABSTRACT The identification of the “culprit lesion” in acute coronary syndromes (ACS) traditionally relies on coronary angiography, assuming that the most severe stenosis, abrupt occlusion, or largest filling defect marks the site of plaque destabilization.
Fernando Quevedo‐Candela +7 more
wiley +1 more source
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome
Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations.
Simon Correa +7 more
doaj +1 more source
To investigate cardiovascular (CV) safety and event rates for dapagliflozin versus other glucose‐lowering drugs (GLDs) in a real‐world type 2 diabetes population after applying the main inclusion criteria and outcomes from the DECLARE‐TIMI 58 study.
A. Norhammar +5 more
semanticscholar +1 more source
ABSTRACT Background Cangrelor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI), with the advantage of rapid onset and offset. However, premature discontinuation may increase the risk of acute thrombosis for patients undergoing complex/high‐risk PCI (CHIP).
Siyu Ma +8 more
wiley +1 more source
Realistic experimental evaluation of time-sensitive communication mechanisms and intrusion detection systems that exploit temporal properties of CAN traffic requires precise control over CAN frame transmission timing, as variations in frame arrival times
Emilia Caragea, Bogdan Groza
doaj +1 more source
ABSTRACT Background Real‐world data after percutaneous coronary intervention (PCI) using drug‐coated balloons (DCBs) in acute coronary syndrome (ACS) are limited. Aims We compared 1‐year clinical outcomes after PCI with paclitaxel DCBs between the ACS and non‐ACS patients.
Takashi Muramatsu +18 more
wiley +1 more source
Thrombolysis in myocardial infarction (TIMI) risk score calculation [6].
Thrombolysis in myocardial infarction (TIMI) risk score calculation [6].
Musa Karim (7042427) +9 more
core +1 more source
Industrial predictive maintenance has recently benefited significantly from advances in machine learning. However, most existing approaches remain limited to experimental model level implementations and lack the system-level infrastructure required for ...
Dragos Brisc +2 more
doaj +1 more source
Background Plasma omega‐3 polyunsaturated fatty acids (ω3‐PUFAs) have been shown to be inversely correlated with the risk of cardiovascular death in primary prevention.
Thomas A. Zelniker +7 more
doaj +1 more source

